NEW SERIES – Cardio-Renal-Metabolic Masterclasses
Tackling important aspects of early diagnosis and protection strategies
Cardio-renal-metabolic (CRM) syndrome, which involves type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and heart failure (HF), is a serious healthcare issue globally, with high morbidity and mortality.
Cardiorenal syndrome can cause a range of severe symptoms and lead to long-term organ damage. The condition can affect a person’s lifespan. While full recovery is unlikely, treatment can reduce symptoms and support the functioning of the heart and kidneys.
There is an unmet need in terms of translating current evidence and guidance into front line clinical practice. These first two programmes, through case presentations, interactive discussion and debate, aim to highlight the importance of identifying diabetic kidney disease and starting an early and aggressive renal protection strategy.
Part 1 – Now available On Demand
Consequences of a late diagnosis of diabetic kidney disease
Late diagnosis of a diabetic kidney disease patient, reinforcing the current evidence and guidance on early diagnosis and renal protection strategies.
Part 2 – Tuesday 28th May, 19:00 to 20:00 hours
Optimising renal protection in non-diabetic kidney disease
Patient with non-diabetic CKD (hypertensive) – focusing on establishing a diagnosis, thresholds for referral and optimising renal protection in non-diabetic kidney disease.
About the series
The overarching objective of the series is to improve the knowledge and confidence of primary care health practitioners in the management of cardio-renal patients with a focus on renal, covering:
- NICE T2DM guidelines and early positioning of SGLT2i – focusing in on patients with CKD on T2DM
- Evidence for SGLT2is in CKD and DKD
- CKD licences and NICE TAs for dapagliflozin and empagliflozin
- Exploring the different cohorts studied in Dapa CKD and Empa Kidney and how they relate to primary care patients
- Revisiting the Empa-reg outcome data
Your experts
Dr Yassir JavaidGPwSI Cardiology & Cardiovascular lead
Professor James Burton
Professor of Renal Medicine and Consultant Nephrologist
You must be an Issues & Answers member* to register for this programme, login below:
*If you are not already a member click here to register for FREE.
This educational programme has been supported by:
Boehringer Ingelheim and Lilly Alliance has provided funding towards this independent Programme. The Alliance has had no editorial input into or influence on the agenda, content of this meeting including the selection of speakers.
The content, opinions and statements made in this programme are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board.
